Omeros | OMER - Koszty Sprzedaży





Koszty Sprzedaży Zmiana Data
Adma Biologics USD 33.74M 16.65M 2026-03
Alnylam Pharmaceuticals USD 211.12M 56.6M 2026-03
BioMarin Pharmaceutical USD 199.48M 37.93M 2026-03
Cytokinetics USD 160K 104.24M 2026-03
Gilead Sciences USD 1.44B 174M 2026-03
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 49.5M 3.34M 2026-03
Knight Therapeutics CAD 82.22M 1.03M 2025-12
MacroGenics USD 9.53M 585K 2026-03
Omeros USD 33.16M 18.52M 2024-06
Pacira USD 50.74M 3.89M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Rockwell Medical USD 21.28M 1.67M 2024-06
Sangamo BioSciences 2.42M 1.11M 2024-06
Sarepta Therapeutics USD 109.46M 289.93M 2026-03
United Therapeutics USD 133.4M 341.3M 2026-03
Vertex Pharmaceuticals USD 392.8M 73.2M 2026-03
Xoma 116K 112.7K 2024-06